IMPACT BIOMEDICAL INC. (IBO) Current Reports & Earnings Releases
| Filed | Form | Items | Filing |
|---|---|---|---|
| 2026-03-04 | 8-K | Material Agreement, Financial Statements & Exhibits | SEC |
| 2025-11-06 | 8-K | Shareholder Vote Results | SEC |
| 2025-10-27 | 8-K | Other Events | SEC |
| 2025-07-28 | 8-K | Material Agreement, Financial Statements & Exhibits | SEC |
| 2025-06-23 | 8-K | Material Agreement, Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2025-04-03 | 8-K | Material Agreement | SEC |
| 2025-03-28 | 8-K | Material Agreement, Financial Statements & Exhibits | SEC |
| 2025-03-13 | 8-K | Officer / Director Changes | SEC |
| 2025-01-29 | 8-K | Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2024-11-04 | 8-K | Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2024-10-08 | 8-K | Officer / Director Changes, Financial Statements & Exhibits | SEC |
| 2024-09-17 | 8-K | Material Agreement, Other Events, Financial Statements & Exhibits | SEC |
| 2024-06-07 | 8-K | Officer / Director Changes | SEC |
| 2024-01-22 | 8-K | Material Agreement, Financial Statements & Exhibits | SEC |
Sourced from SEC EDGAR 8-K/6-K filings. 8-K is the current-report form for US domestic issuers (Item 2.02 = earnings release); 6-K is the equivalent for foreign private issuers, including ADRs. Originals live on sec.gov.